Long-term investors. Strategic partners. Trusted advisors.
MTIP is a Swiss-based growth investor that specializes in scaling up healthtech companies in rapidly expanding global markets. We invest in digitally-connected, decentralized and patient-centric medical technology leaders, based primarily in Europe, with offerings that provide clear health-related economic benefits. Our entrepreneurial investment team, which has complementary private equity skills and exceptional deal-making capabilities, actively works with our portfolio companies to boost growth. MTIP efficiently deploys capital to unlock value and generate attractive returns for our investors.
Our brand promises
MTIP's new investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
The digital healthtech sector is expanding – and so are we!
MTIP has sucessfully exited Blueprint Genetics